Logo image of CFXA

COLFAX CORP (CFXA) Stock Fundamental Analysis

USA - NYSE:CFXA -

177.71
-2.39 (-1.33%)
Last: 1/14/2022, 8:17:08 PM
177
-0.71 (-0.4%)
After Hours: 1/14/2022, 8:17:08 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CFXA. CFXA was compared to 129 industry peers in the Machinery industry. CFXA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CFXA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CFXA had positive earnings in the past year.
CFXA Yearly Net Income VS EBIT VS OCF VS FCFCFXA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA 1.34%
ROE 2.33%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CFXA Yearly ROA, ROE, ROICCFXA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5 -10 -15

1.3 Margins

Industry RankSector Rank
OM 8.8%
PM (TTM) 2.92%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CFXA Yearly Profit, Operating, Gross MarginsCFXA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CFXA has been increased compared to 1 year ago.
The debt/assets ratio for CFXA has been reduced compared to a year ago.
CFXA Yearly Shares OutstandingCFXA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M
CFXA Yearly Total Debt VS Total AssetsCFXA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2B 4B 6B

2.2 Solvency

An Altman-Z score of 5.65 indicates that CFXA is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.35 indicates that CFXA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 5.65
ROIC/WACCN/A
WACCN/A
CFXA Yearly LT Debt VS Equity VS FCFCFXA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.77 indicates that CFXA should not have too much problems paying its short term obligations.
CFXA has a Quick Ratio of 1.77. This is a bad value and indicates that CFXA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 0.97
CFXA Yearly Current Assets VS Current LiabilitesCFXA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

CFXA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.58%, which is quite impressive.
Measured over the past years, CFXA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.90% on average per year.
The Revenue has grown by 16.86% in the past year. This is quite good.
The Revenue has been decreasing by -2.21% on average over the past years.
EPS 1Y (TTM)37.58%
EPS 3Y-5.56%
EPS 5Y-2.9%
EPS Q2Q%31.71%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y16.6%
Revenue growth 5Y-2.21%
Sales Q2Q%19.85%

3.2 Future

CFXA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.70% yearly.
Based on estimates for the next years, CFXA will show a quite strong growth in Revenue. The Revenue will grow by 10.02% on average per year.
EPS Next Y54.37%
EPS Next 2Y36.22%
EPS Next 3Y27.67%
EPS Next 5Y22.7%
Revenue Next Year25.16%
Revenue Next 2Y16.53%
Revenue Next 3Y12.59%
Revenue Next 5Y10.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CFXA Yearly Revenue VS EstimatesCFXA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
CFXA Yearly EPS VS EstimatesCFXA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 86.69, which means the current valuation is very expensive for CFXA.
Compared to an average S&P500 Price/Earnings ratio of 27.67, CFXA is valued quite expensively.
With a Price/Forward Earnings ratio of 68.90, CFXA can be considered very expensive at the moment.
When comparing the Price/Forward Earnings ratio of CFXA to the average of the S&P500 Index (23.13), we can say CFXA is valued expensively.
Industry RankSector Rank
PE 86.69
Fwd PE 68.9
CFXA Price Earnings VS Forward Price EarningsCFXA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.51
CFXA Per share dataCFXA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CFXA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CFXA's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)1.59
PEG (5Y)N/A
EPS Next 2Y36.22%
EPS Next 3Y27.67%

More info and screens

0

5. Dividend

5.1 Amount

CFXA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COLFAX CORP

NYSE:CFXA (1/14/2022, 8:17:08 PM)

After market: 177 -0.71 (-0.4%)

177.71

-2.39 (-1.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.51B
Analysts77
Price Target229.41 (29.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 86.69
Fwd PE 68.9
P/S 7.52
P/FCF N/A
P/OCF N/A
P/B 6
P/tB N/A
EV/EBITDA 49.51
EPS(TTM)2.05
EY1.15%
EPS(NY)2.58
Fwd EY1.45%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS23.64
BVpS29.63
TBVpSN/A
PEG (NY)1.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 2.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.8%
PM (TTM) 2.92%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 0.97
Altman-Z 5.65
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.58%
EPS 3Y-5.56%
EPS 5Y-2.9%
EPS Q2Q%31.71%
EPS Next Y54.37%
EPS Next 2Y36.22%
EPS Next 3Y27.67%
EPS Next 5Y22.7%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y16.6%
Revenue growth 5Y-2.21%
Sales Q2Q%19.85%
Revenue Next Year25.16%
Revenue Next 2Y16.53%
Revenue Next 3Y12.59%
Revenue Next 5Y10.02%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A